Immune-mediated Necrotizing Myopathy With Increased Creatine Phosphokinase and Positive Signal Recognition Particle: A Case Report

Q4 Medicine
Seyed Mohammad Masoud Hojati, P. Saadat, S. Alijanpour
{"title":"Immune-mediated Necrotizing Myopathy With Increased Creatine Phosphokinase and Positive Signal Recognition Particle: A Case Report","authors":"Seyed Mohammad Masoud Hojati, P. Saadat, S. Alijanpour","doi":"10.32598/cjns.8.30.1","DOIUrl":null,"url":null,"abstract":"Background: Knowledge about Immune-Mediated Necrotizing Myopathy (IMNM) has received significantly attention in recent years. In this study, we report a rare case of IMNM with increased Creatine Phosphokinase (CPK) and positive Signal Recognition Particle (SRP). Clinical Presentation and Intervention: The case was a 67-year-old male patient referred to Firozgar hospital affiliated to the Iran University of Medical Science, Tehran, Iran in June 2018 with a chief complaint of pain in the proximal lower extremity. According to Medical Research Council Scale for muscle strength, the motor function of proximal upper extremities was 4/5 and for the proximal of the lower extremities, it was 3/5. Laboratory findings showed an increase in CPK, CK-MB, lactate dehydrogenase, creatinine, alanine aminotransferase, aspartate aminotransferase and aldolase levels. Six days after admission, autoantibody test was requested which showed positive SRP. In muscle biopsy, the myopathic atrophy with multiple necrotic and many degenerative/regenerative fibers was associated with mild endomysial fibrosis, and no inflammation was observed. Two g/kg dose of Intravenous Immunoglobulin (IVIG) was administrated after diagnosis of IMNM. Prednisone 50 mg/day orally, calcium vitamin D daily, pantoprazole 40 mg/day, physiotherapy, and occupational therapy were administrated for after discharge. Conclusion: Reporting a case of anti-SRP associated IMNM and reviewing its pathophysiology, diagnosis and treatment options can help increase the physicians’ knowledge of this rare and debilitating condition.","PeriodicalId":31302,"journal":{"name":"Caspian Journal of Neurological Sciences","volume":"36 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Caspian Journal of Neurological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32598/cjns.8.30.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Knowledge about Immune-Mediated Necrotizing Myopathy (IMNM) has received significantly attention in recent years. In this study, we report a rare case of IMNM with increased Creatine Phosphokinase (CPK) and positive Signal Recognition Particle (SRP). Clinical Presentation and Intervention: The case was a 67-year-old male patient referred to Firozgar hospital affiliated to the Iran University of Medical Science, Tehran, Iran in June 2018 with a chief complaint of pain in the proximal lower extremity. According to Medical Research Council Scale for muscle strength, the motor function of proximal upper extremities was 4/5 and for the proximal of the lower extremities, it was 3/5. Laboratory findings showed an increase in CPK, CK-MB, lactate dehydrogenase, creatinine, alanine aminotransferase, aspartate aminotransferase and aldolase levels. Six days after admission, autoantibody test was requested which showed positive SRP. In muscle biopsy, the myopathic atrophy with multiple necrotic and many degenerative/regenerative fibers was associated with mild endomysial fibrosis, and no inflammation was observed. Two g/kg dose of Intravenous Immunoglobulin (IVIG) was administrated after diagnosis of IMNM. Prednisone 50 mg/day orally, calcium vitamin D daily, pantoprazole 40 mg/day, physiotherapy, and occupational therapy were administrated for after discharge. Conclusion: Reporting a case of anti-SRP associated IMNM and reviewing its pathophysiology, diagnosis and treatment options can help increase the physicians’ knowledge of this rare and debilitating condition.
免疫介导的坏死性肌病伴肌酸磷酸激酶升高和阳性信号识别颗粒:1例报告
背景:近年来,关于免疫介导的坏死性肌病(IMNM)的知识受到了极大的关注。在这项研究中,我们报告了一例罕见的肌酸磷酸激酶(CPK)升高和信号识别粒子(SRP)阳性的IMNM病例。临床表现和干预措施:该病例为一名67岁男性患者,于2018年6月转诊至伊朗德黑兰伊朗医科大学附属firrozgar医院,主诉为下肢近端疼痛。根据医学研究委员会肌肉力量量表,上肢近端运动功能为4/5,下肢近端运动功能为3/5。实验室结果显示CPK、CK-MB、乳酸脱氢酶、肌酐、丙氨酸转氨酶、天冬氨酸转氨酶和醛缩酶水平升高。入院后6天进行自身抗体检测,结果显示SRP阳性。在肌肉活检中,多发性坏死和许多退行性/再生纤维的肌病萎缩与轻度肌内膜纤维化相关,未观察到炎症。诊断为IMNM后给予静脉注射免疫球蛋白(IVIG) 2 g/kg。出院后给予强的松50 mg/天口服,维生素D钙每日,泮托拉唑40 mg/天,物理治疗和职业治疗。结论:报告一例抗srp相关的IMNM,并回顾其病理生理、诊断和治疗方案,有助于提高医生对这种罕见且使人衰弱的疾病的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Caspian Journal of Neurological Sciences
Caspian Journal of Neurological Sciences Neuroscience-Neuroscience (miscellaneous)
CiteScore
0.60
自引率
0.00%
发文量
39
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书